Owens & Minor Faces Dual Challenge After Index Removal

The medical logistics firm Owens & Minor is confronting a significant market test following its upcoming expulsion from the S&P SmallCap 600 Index. This development compounds existing pressures as the company navigates a complex strategic overhaul, raising questions about near-term stock performance.

At the core of Owens & Minor’s current challenges is a fundamental strategic pivot. The company is intensifying its focus on the Patient Direct business, which encompasses homecare and medical direct supply services, while moving away from its lower-margin Products & Healthcare Services operations. This restructuring carries a substantial cost.

A clear illustration of the financial strain is the aftermath of the failed $1.36 billion acquisition of Rotech Healthcare. The deal’s collapse resulted in Read more...